[go: up one dir, main page]

NO20052176L - Legemiddel som omfatter et tiourea for anvendelse som et depigmenteringsmiddel, eller antimutagent og antikarsinogent middel - Google Patents

Legemiddel som omfatter et tiourea for anvendelse som et depigmenteringsmiddel, eller antimutagent og antikarsinogent middel

Info

Publication number
NO20052176L
NO20052176L NO20052176A NO20052176A NO20052176L NO 20052176 L NO20052176 L NO 20052176L NO 20052176 A NO20052176 A NO 20052176A NO 20052176 A NO20052176 A NO 20052176A NO 20052176 L NO20052176 L NO 20052176L
Authority
NO
Norway
Prior art keywords
thiourea
antimut
depigmentant
anticarcinogen
drug
Prior art date
Application number
NO20052176A
Other languages
English (en)
Inventor
Cherif Rabhi
Veronique Schwaab
Daniel Jean
Original Assignee
Lmd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lmd filed Critical Lmd
Publication of NO20052176L publication Critical patent/NO20052176L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782—Enzyme inhibitors; Enzyme antagonists

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Ophthalmology & Optometry (AREA)
  • Neurosurgery (AREA)
  • Toxicology (AREA)
  • Neurology (AREA)
  • Nutrition Science (AREA)
  • Biomedical Technology (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Oppfinnelsen angår en medisinsk eller en kosmetisk sammensetning som omfatter minst ett tiourea med generell formel (I), eller minst ett av dets monoksid-eller dioksidderivater med generell formel (Ila), (Ilb), og (III) eller blandinger derav. Dette legemiddel blir fordelaktig brukt til å inhibere tyrosinase, inhibere melaninsyntese, til å lysne eller depigmentere huden for å eliminere aldersflekker og som antimutagent og antikarsinogent middel.
NO20052176A 2002-10-11 2005-05-03 Legemiddel som omfatter et tiourea for anvendelse som et depigmenteringsmiddel, eller antimutagent og antikarsinogent middel NO20052176L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0212697A FR2845599B1 (fr) 2002-10-11 2002-10-11 Medicament comprenant une thiouree pour son utilisation en tant que depigmentant
PCT/FR2003/002907 WO2004032912A1 (fr) 2002-10-11 2003-10-03 Medicament comprenant une thiouree pour son utilisation en tant que depigmentant ou agent antimutagene et anticarcinogene

Publications (1)

Publication Number Publication Date
NO20052176L true NO20052176L (no) 2005-05-03

Family

ID=32039668

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20052176A NO20052176L (no) 2002-10-11 2005-05-03 Legemiddel som omfatter et tiourea for anvendelse som et depigmenteringsmiddel, eller antimutagent og antikarsinogent middel

Country Status (12)

Country Link
US (1) US20060135618A1 (no)
EP (1) EP1553933B1 (no)
JP (1) JP2006509733A (no)
KR (1) KR20050094806A (no)
AT (1) ATE367807T1 (no)
AU (1) AU2003286213A1 (no)
CA (1) CA2501742A1 (no)
DE (1) DE60315176D1 (no)
FR (1) FR2845599B1 (no)
MX (1) MXPA05003891A (no)
NO (1) NO20052176L (no)
WO (1) WO2004032912A1 (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2881654B1 (fr) * 2005-02-07 2009-05-29 Lmd Compositions medicinales contenant une alkylsulfone pour le traitement du cancer en association a des agents chimiotherapeutiques ou a des rayonnements ionisants ou non ionisants
WO2007039821A2 (en) * 2005-08-31 2007-04-12 Galderma Research & Development Novel inhibitors of tyrosinase, their method of preparation and their use in human medicine and in cosmetics
FR2890070A1 (fr) * 2005-08-31 2007-03-02 Galderma Res & Dev Nouveaux inhibiteurs de la tyrosinase, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique
WO2008015315A1 (fr) * 2006-08-03 2008-02-07 Lmd Compositions medicinales contenant une thiouree pour le traitement du cancer en association avec des agents chimiotherapeutiques ou des rayonnements ionisants ou non ionisants
EA201270016A1 (ru) * 2009-06-09 2012-06-29 Марди Медисинс Лтд. Галогенированные алифатические карбоновые кислоты, их олигомеры и/или полимеры и их применение для девитализации внешних и внутренних новообразований
BE1019432A3 (fr) * 2010-07-23 2012-07-03 Auriga Internat Utilisation d'isothiocyanates et derives pour le traitement et/ou la prevention des lucites.
BE1019431A3 (fr) * 2010-07-23 2012-07-03 Auriga Internat Procede de synthese d'isothiocyanates et leurs derives et utilisations de ceux-ci.
EP2854861B1 (en) 2012-06-01 2017-10-04 Pharmagra Labs, Inc. Method of synthesising sulforaphane
TWI508950B (zh) * 2014-08-29 2015-11-21 Univ Hungkuang 3-methyl-2-sulfanyl-2,3-dihydro-1H-imidazole-1-carboxylic acid Tertiary butyl ester and its preparation method and use
WO2018046243A1 (en) 2016-09-06 2018-03-15 Unilever N.V. Compounds for reducing cellular melanin content
KR102201385B1 (ko) * 2018-10-11 2021-01-11 주식회사 그라젬 피부 미백용 조성물 및 이를 이용한 미백용 화장품

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5411986A (en) * 1993-03-12 1995-05-02 The Johns Hopkins University Chemoprotective isothiocyanates
EP1267868B1 (en) * 2000-02-29 2007-07-18 MediQuest Therapeutics, Inc. Inhibitors of melanocyte tyrosinase as topical skin lighteners
FR2820036B1 (fr) * 2001-01-26 2005-12-09 L M D Utilisation d'un isothiocyanate, d'un thiocyanate ou de leur melange en tant que depigmentant

Also Published As

Publication number Publication date
EP1553933A1 (fr) 2005-07-20
FR2845599A1 (fr) 2004-04-16
CA2501742A1 (fr) 2004-04-22
MXPA05003891A (es) 2005-08-03
FR2845599B1 (fr) 2005-01-07
EP1553933B1 (fr) 2007-07-25
US20060135618A1 (en) 2006-06-22
AU2003286213A1 (en) 2004-05-04
JP2006509733A (ja) 2006-03-23
WO2004032912A1 (fr) 2004-04-22
DE60315176D1 (de) 2007-09-06
ATE367807T1 (de) 2007-08-15
KR20050094806A (ko) 2005-09-28

Similar Documents

Publication Publication Date Title
NO20052176L (no) Legemiddel som omfatter et tiourea for anvendelse som et depigmenteringsmiddel, eller antimutagent og antikarsinogent middel
HUP0400206A2 (hu) Metalloproteináz inhibitor hatású imidazolidin-dion-származékok, ezek alkalmazása gyógyszerkészítmények előállítására és ezeket tartalmazó gyógyszerkészítmények
NO20051209L (no) Pyrazolderivater, medisinske sammensetninger inneholdende slike, medisinsk anvendelse derav samt intermediater for samme
BR0213079A (pt) Forma de dosagem para o tratamento da diabetes mellitus
AR035631A1 (es) Compuestos quimicos
AR021419A1 (es) El empleo de compuestos no esteroides para preparar medicamentos antiinflamatorios, los compuestos no esteroides que son apropiados para este empleo y lospreparados farmaceuticos que contienen estos ultimos compuestos
BR0009563A (pt) Inibidores de ap2 de bifenilas contendo heterocìclico e método
BR9809968A (pt) Aplicação de derivados tiazolidinadiona no tratamento da pcos e diabetes gestacional
NO20074390L (no) Forsterket bimatoprost oye-opplosning
HUP0202570A1 (hu) Izoflavonokat és analogonjait tartalmazó készítmények és terápiás alkalmazásuk
BR0209468A (pt) Composto ou sais ou solvatos deste farmaceuticamente aceitáveis, composição farmacêutica, uso de um composto, e, método de tratamento de uma doença ou condição mediada pelo hppar
AR016817A1 (es) Derivados de fenilurea o feniltiourea, procedimiento para su preparacion, coleccion de compuestos, compuestos intermediarios, composicion farmaceutica,metodo de tratamiento y uso de dichos compuestos para la manufactura de un medicamento
DK0396165T3 (da) Farmaceutisk præparat til oral indgift til gastrointestinal udskylning eller som katarlaxativ
BR0311952A (pt) Novos compostos úteis para o tratamento de obesidade, diabetes tipo ii e distúrbios do snc
NO20085077L (no) Nye forbindelser
MA27932A1 (fr) Derives du dioxyde de benzoisothiazole/thiazole substitues, procede de production et utilisation desdits derives
CR6861A (es) Derivados de imidazol
NO20060342L (no) 1-sulfonylindol derivater, deres fremstilling og deres andvendelse som 5-HT6 ligander
DK1261593T3 (da) 8,8a-Dihydro-indeno[1,2-d]thiazol-derivater med en sulfonamido- eller sulfonosubstituent i 2-stillingen, en fremgangsmåde til fremstilling deraf og anvendelse deraf som lægemiddel
AR032466A1 (es) Ciclilamina sulfonamidas, utilizacion de las mismas para la manufactura de un medicamento y composiciones farmaceuticas utiles como agonistas de los receptores beta-3 adrenergicos
EA200600694A1 (ru) Дисульфидные, сульфидные, сульфоксидные и сульфоновые производные циклических сахаров и их применение
NO20040881L (no) Orale antidiabetes midler.
HUP0202384A2 (hu) Szubsztituált fenoxiecetsav-származékok
BR0114424A (pt) Derivados de 5-amidino-2-hidróxi benzeno sulfonamida, composições farmacêuticas contendo os mesmos e intermediários para a sua preparação
NO20050573L (no) 4-&#39;7-halo-2-quino (XA) linyloksy ! fenoksypropionsyrederivater som antineoplastiske midler